These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 29122659)

  • 41. Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease.
    Moreira AP; Cavassani KA; Hullinger R; Rosada RS; Fong DJ; Murray L; Hesson DP; Hogaboam CM
    J Allergy Clin Immunol; 2010 Oct; 126(4):712-721.e7. PubMed ID: 20673988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis.
    Crameri R; Hemmann S; Ismail C; Menz G; Blaser K
    Int Immunol; 1998 Aug; 10(8):1211-6. PubMed ID: 9723708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative performance of Aspergillus galactomannan ELISA and PCR in sputum from patients with ABPA and CPA.
    Fayemiwo S; Moore CB; Foden P; Denning DW; Richardson MD
    J Microbiol Methods; 2017 Sep; 140():32-39. PubMed ID: 28645480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Cuthbertson L; Felton I; James P; Cox MJ; Bilton D; Schelenz S; Loebinger MR; Cookson WOC; Simmonds NJ; Moffatt MF
    J Cyst Fibros; 2021 Mar; 20(2):295-302. PubMed ID: 32540174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The oral fungal mycobiome: characteristics and relation to periodontitis in a pilot study.
    Peters BA; Wu J; Hayes RB; Ahn J
    BMC Microbiol; 2017 Jul; 17(1):157. PubMed ID: 28701186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of HIV/HAART and Other Clinical Variables on the Oral Mycobiome Using Multivariate Analyses.
    Fidel PL; Thompson ZA; Lilly EA; Granada C; Treas K; Dubois KR; Cook L; Hashmi SB; Lisko DJ; Mukherjee C; Vazquez JA; Hagensee ME; Griffen AL; Leys EJ; Beall CJ
    mBio; 2021 Mar; 12(2):. PubMed ID: 33758093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The gut mycobiome of the Human Microbiome Project healthy cohort.
    Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
    Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Allergic bronchopulmonary aspergillosis (allergic bronchopulmonary fungal diseases)].
    Kino T
    Nihon Rinsho; 1993 Mar; 51(3):765-70. PubMed ID: 8492455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allergic bronchopulmonary aspergillosis: an Indian perspective.
    Shah A
    Curr Opin Pulm Med; 2007 Jan; 13(1):72-80. PubMed ID: 17133129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Burden of serious fungal infections in Nepal.
    Khwakhali US; Denning DW
    Mycoses; 2015 Oct; 58 Suppl 5():45-50. PubMed ID: 26449506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.
    Terashima T; Shinozaki T; Iwami E; Nakajima T; Matsuzaki T
    BMC Pulm Med; 2018 Mar; 18(1):53. PubMed ID: 29587693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.
    Agbetile J; Fairs A; Desai D; Hargadon B; Bourne M; Mutalithas K; Edwards R; Morley JP; Monteiro WR; Kulkarni NS; Green RH; Pavord ID; Bradding P; Brightling CE; Wardlaw AJ; Pashley CH
    Clin Exp Allergy; 2012 May; 42(5):782-91. PubMed ID: 22515394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Automated specific IgE assay with recombinant allergens: evaluation of the recombinant Aspergillus fumigatus allergen I in the Pharmacia Cap System.
    Crameri R; Lidholm J; Grönlund H; Stüber D; Blaser K; Menz G
    Clin Exp Allergy; 1996 Dec; 26(12):1411-9. PubMed ID: 9027442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomedically important pathogenic fungi detection with volatile biomarkers.
    Bazemore RA; Feng J; Cseke L; Podila GK
    J Breath Res; 2012 Mar; 6(1):016002. PubMed ID: 22233561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Challenging cases in fungal asthma.
    Agarwal R; Sehgal IS; Dhooria S; Aggarwal AN
    Med Mycol; 2019 Apr; 57(Supplement_2):S110-S117. PubMed ID: 30816974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis among asthma patients in eastern India.
    Ghosh T; Dey A; Biswas D; Chatterjee S; Haldar N; Maiti PK
    J Indian Med Assoc; 2010 Dec; 108(12):863-5. PubMed ID: 21661466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Asp f6, an Aspergillus allergen specifically recognized by IgE from patients with allergic bronchopulmonary aspergillosis, is differentially expressed during germination.
    Schwienbacher M; Israel L; Heesemann J; Ebel F
    Allergy; 2005 Nov; 60(11):1430-5. PubMed ID: 16197477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fungi and allergic lower respiratory tract diseases.
    Knutsen AP; Bush RK; Demain JG; Denning DW; Dixit A; Fairs A; Greenberger PA; Kariuki B; Kita H; Kurup VP; Moss RB; Niven RM; Pashley CH; Slavin RG; Vijay HM; Wardlaw AJ
    J Allergy Clin Immunol; 2012 Feb; 129(2):280-91; quiz 292-3. PubMed ID: 22284927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans.
    Wardhana ; Datau EA
    Acta Med Indones; 2012 Oct; 44(4):317-23. PubMed ID: 23314973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fungi in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Moss RB
    Semin Respir Crit Care Med; 2015 Apr; 36(2):207-16. PubMed ID: 25826588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.